BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30971293)

  • 1. Clinical versus histological grading in the assessment of cutaneous graft versus host disease.
    Hogenes MCH; Te Boome LCJ; van der Valk DC; van Dijk MR; de Weger RA; Kuball J; van Diest PJ
    Eur J Med Res; 2019 Apr; 24(1):19. PubMed ID: 30971293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
    Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.
    Weisdorf DJ; Hurd D; Carter S; Howe C; Jensen LA; Wagner J; Stablein D; Thompson J; Kernan NA
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):512-8. PubMed ID: 12931120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
    Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confocal endomicroscopy in diagnosis of intestinal chronic graft-versus-host disease.
    Rieger K; Günther U; Erben U; Kühl A; Loddenkemper C; Pezzutto A; Siegmund B; Bojarski C
    Hematol Oncol; 2018 Feb; 36(1):291-298. PubMed ID: 28547857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.
    Myerson D; Steinbach G; Gooley TA; Shulman HM
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1573-1579. PubMed ID: 28533059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.
    Sauvestre F; Belleannée G; Bréal C; Mohr C; Fong HI; Cossin S; Tabrizi R; Milpied N; Vigouroux S; Goussot JF; Marty M
    Virchows Arch; 2018 Feb; 472(2):213-220. PubMed ID: 29167990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease.
    Kreft A; Hippe K; Wagner-Drouet EM; Ries I; Kandulski A; Büttner-Herold M; Neumann H; Weber D; Holler E; Schindeldecker M
    PLoS One; 2021; 16(8):e0256543. PubMed ID: 34437603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
    Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
    Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
    Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperacute graft-versus-host disease: histological assessment of skin biopsy specimens from 19 cases.
    Shiohara J; Takata M; Shiohara M; Ito T; Ishida F
    Clin Exp Dermatol; 2012 Jun; 37(4):335-40. PubMed ID: 22276575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation].
    Deng XR; Ren HY; Cen XN; Wang LH; Liang ZY; Wang WS; Qiu ZX; Ou JP; Xu WL; Wang MJ; Li Y; Yin Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):994-8. PubMed ID: 19698246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
    Brüggen MC; Petzelbauer P; Greinix H; Contassot E; Jankovic D; French L; Socié G; Rabitsch W; Kuzmina Z; Kalhs P; Knobler R; Stingl G; Stary G
    J Invest Dermatol; 2015 Apr; 135(4):999-1006. PubMed ID: 25405322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.
    Gaziev D; Polchi P; Galimberti M; Angelucci E; Giardini C; Baronciani D; Erer B; Lucarelli G
    Transplantation; 1997 Mar; 63(6):854-60. PubMed ID: 9089226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aGVHD and cGVHD according to relapse status on survival rate in patients with acute lymphocytic leukemia.
    Sayehmiri K; Carson KV; Bakhtiyari S; Shokouhi S; Alimoghadam K
    Hematology; 2014 Dec; 19(8):441-7. PubMed ID: 24620946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous graft-versus-host reaction: prognostic features seen by light microscopy.
    Hymes SR; Farmer ER; Lewis PG; Tutschka PJ; Santos GW
    J Am Acad Dermatol; 1985 Mar; 12(3):468-74. PubMed ID: 3989008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
    Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
    JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
    Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.